Birchview Capital

Latest statistics and disclosures from Birchview Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BMY, AXDX, QDEL, AWH, NBIX, and represent 67.59% of Birchview Capital's stock portfolio.
  • Added to shares of these 6 stocks: QDEL, BMY.R, ACAD, ALBO, AMRN, BMY.
  • Reduced shares in these 4 stocks: GILD, AWH, NARI, WKHS.
  • Sold out of its positions in GILD.
  • Birchview Capital was a net buyer of stock by $2.0M.
  • Birchview Capital has $150M in assets under management (AUM), dropping by -9.54%.

Tip: Access up to 7 years of quarterly data

Positions held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Birchview Capital

Companies in the Birchview Capital portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bristol Myers Squibb (BMY) 32.0 $48M 794k 60.29
Accelr8 Technology (AXDX) 15.6 $23M 2.2M 10.66
Quidel Corporation (QDEL) 8.6 $13M +15% 59k 219.37
Aspira Womens Health (AWH) 6.4 $9.5M -6% 3.1M 3.08
Neurocrine Biosciences (NBIX) 5.0 $7.5M 78k 96.15
ACADIA Pharmaceuticals (ACAD) 2.8 $4.2M +9% 102k 41.25
Bluebird Bio (BLUE) 2.2 $3.2M 60k 53.95
Biogen Idec (BIIB) 2.1 $3.1M 11k 283.64
Bmy Cvr Rts 03/31/21 Right (BMY.R) 1.8 $2.7M +70% 1.2M 2.25
Karyopharm Therapeutics (KPTI) 1.6 $2.5M 168k 14.60
Acceleron Pharma (XLRN) 1.4 $2.1M 19k 112.52
Soleno Therapeutics 1.4 $2.1M 827k 2.51
Oxford Immunotec Global (OXFD) 1.3 $2.0M 170k 11.70
Albireo Pharma (ALBO) 1.3 $1.9M +20% 58k 33.36

Setup an alert

Birchview Capital will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Masimo Corporation (MASI) 1.3 $1.9M 8.0k 236.00
United Therapeutics Corporation (UTHR) 1.2 $1.8M 18k 101.00
Arena Pharmaceuticals (ARNA) 1.1 $1.6M 22k 74.77
Chemocentryx (CCXI) 1.1 $1.6M 30k 54.80
Myokardia (MYOK) 0.9 $1.4M 10k 136.30
Contrafect 0.9 $1.3M 256k 5.28
Amarin Corp Spons Adr New (AMRN) 0.8 $1.3M +15% 300k 4.21
Equitrans Midstream Corp (ETRN) 0.8 $1.1M 133k 8.46
Harrow Health (HROW) 0.7 $1.0M 180k 5.59
Corcept Therapeutics Incorporated (CORT) 0.6 $870k 50k 17.40
Epizyme (EPZM) 0.6 $835k 70k 11.93
Vanda Pharmaceuticals (VNDA) 0.5 $773k 80k 9.66
ImmunoGen (IMGN) 0.5 $684k 190k 3.60
Stoke Therapeutics (STOK) 0.4 $670k 20k 33.50
Biohaven Pharmaceutical Holding (BHVN) 0.4 $650k 10k 65.00
Amicus Therapeutics (FOLD) 0.4 $537k 38k 14.13
Inari Medical Ord (NARI) 0.3 $483k -30% 7.0k 69.00
Xencor (XNCR) 0.3 $477k 12k 38.78
Continental Resources (CLR) 0.3 $474k 39k 12.28
G1 Therapeutics (GTHX) 0.3 $462k 40k 11.55
Progyny (PGNY) 0.3 $441k 15k 29.40
Translate Bio (TBIO) 0.3 $408k 30k 13.60
Tg Therapeutics (TGTX) 0.3 $401k 15k 26.73
Kalvista Pharmaceuticals (KALV) 0.3 $378k 30k 12.60
Arvinas Ord (ARVN) 0.2 $354k 15k 23.60
Intercept Pharmaceuticals In (ICPT) 0.2 $344k 8.3k 41.45
Pioneer Natural Resources (PXD) 0.2 $327k 3.8k 86.05
Voyager Therapeutics (VYGR) 0.2 $320k 30k 10.67
Inflarx Nv (IFRX) 0.2 $298k 70k 4.26
Encana Corporation (OVV) 0.2 $280k 34k 8.15
Odonate Therapeutics Ord (ODT) 0.2 $269k 20k 13.45
Apellis Pharmaceuticals (APLS) 0.2 $241k 8.0k 30.12
Workhorse Group Inc ordinary shares (WKHS) 0.1 $202k -46% 8.0k 25.25
Dicerna Pharmaceuticals (DRNA) 0.1 $180k 10k 18.00
Yield10 Bioscience 0.1 $147k 19k 7.76
BioCryst Pharmaceuticals (BCRX) 0.0 $69k 20k 3.45

Past Filings by Birchview Capital

SEC 13F filings are viewable for Birchview Capital going back to 2014

View all past filings